Login

Mirati Therapeutics, Inc. SEC Filings

Filed On Filing
14 Feb 2024 SC 13G
14 Feb 2024 SC 13G/A
14 Feb 2024 MIRATI THERAPEUTICS, INC.
14 Feb 2024 MIRATI THERAPEUTICS, INC.
13 Feb 2024 SCHEDULE 13G/A
09 Feb 2024 MS AMENDMENT
09 Feb 2024 MS INITIAL
08 Feb 2024 SEC SCHEDULE 13G
02 Feb 2024 15-12G
31 Jan 2024 SC 13G
25 Jan 2024 Form 4: Boxer Capital, Llc, See remarks and 8 others

Returned 6,859,544 shares to the issuer · Disposed of 5,324,320 Warrant (right to purchase) (Disposition to Issuer)

25 Jan 2024 SC 13D/A
24 Jan 2024 EFFECT
24 Jan 2024 EFFECT
24 Jan 2024 EFFECT
23 Jan 2024 Form 4: Sharp Shalini, Director

Returned 16,222 shares to the issuer · Disposed of 7,520 Option to Purchase Common Stock (Disposition to Issuer)

23 Jan 2024 Form 4: Cherrington Julie M, Director

Returned 11,252 shares to the issuer · Disposed of 7,520 Option to Purchase Common Stock (Disposition to Issuer)

23 Jan 2024 Form 4: Davis Aaron I., Director

Returned 54,325 shares to the issuer · Disposed of 43,520 Option to Purchase Common Stock (Disposition to Issuer)

23 Jan 2024 Form 4: Carter Bruce L A, Director

Returned 17,273 shares to the issuer · Disposed of 28,520 Option to Purchase Common Stock (Disposition to Issuer)

23 Jan 2024 Form 4: Johnson Craig A, Director

Returned 17,273 shares to the issuer · Disposed of 56,520 Option to Purchase Common Stock (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support